# Meloxicam Versus Ibuprofen for Pain Control After Third Molar Exodontia in Adult Patients

> **NCT06704113** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Universidad Austral de Chile** · enrollment: 68 (estimated)

## Conditions studied

- Dental Pain
- Sensation Disorders

## Interventions

- **DRUG:** meloxicam 7,5mg

## Key facts

- **NCT ID:** NCT06704113
- **Lead sponsor:** Universidad Austral de Chile
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-15
- **Primary completion:** 2025-01-15
- **Final completion:** 2025-01-20
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2024-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06704113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06704113, "Meloxicam Versus Ibuprofen for Pain Control After Third Molar Exodontia in Adult Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06704113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*